Approaching the quality of antibiotic prescriptions in primary care using reimbursement data

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 3, 2013, Pages 325-332

  Pulcini, C ^a,b,c   Lions, C ^c,d,e   Ventelou, B ^c,d,e,f   Verger, P ^c,d,e  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c AIX MARSEILLE UNIV   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^f CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; FOSFOMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; NITROFURANTOIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROMETAMOL;

ADULT; AGED; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REIMBURSEMENT, INCENTIVE; YOUNG ADULT;

EID: 84874114233     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1743-2     Document Type: Article

References (32)

1. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 66(Suppl 6):vi3-vi12. doi: 10.1093/jac/dkr453
2. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 6(6):e1000084. doi: 10.1371/journal.pmed.1000084
3. Chahwakilian P, Huttner B, Schlemmer B, Harbarth S (2011) Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother 66(12):2872-2879. doi: 10.1093/jac/dkr387
4. Steinke DT, Bain DJ, MacDonald TM, Davey PG (2000) Practice factors that influence antibiotic prescribing in general practice in Tayside. J Antimicrob Chemother 46(3):509-512
5. De Sutter AI, De Meyere MJ, De Maeseneer JM, Peersman WP (2001) Antibiotic prescribing in acute infections of the nose or sinuses: a matter of personal habit? Fam Pract 18(2):209-213
6. Johnson Z, Hayes C, Dack P (1997) The standardized prescribing ratio - a new method for comparing prescribing between GPs, controlling for patient age and sex. Pharmacoepidemiol Drug Saf 6(5):337-345. doi: 10.1002/(SICI)1099- 1557(199709/10)6:5<337::AID-PDS298>3.0.CO;2-P
7. Cadieux G, Abrahamowicz M, Dauphinee D, Tamblyn R (2011) Are physicians with better clinical skills on licensing examinations less likely to prescribe antibiotics for viral respiratory infections in ambulatory care settings? Med Care 49(2):156-165. doi: 10.1097/MLR.0b013e3182028c1a
8. Wang KY, Seed P, Schofield P, Ibrahim S, Ashworth M (2009) Which practices are high antibiotic prescribers? A cross-sectional analysis. Br J Gen Pract 59(567):e315-e320. doi: 10.3399/bjgp09X472593
9. Gjelstad S, Dalen I, Lindbaek M (2009) GPs' antibiotic prescription patterns for respiratory tract infections - still room for improvement. Scand J Prim Health Care 27(4):208-215. doi: 10.3109/02813430903438718
10. Adriaenssens N, Coenen S, Tonkin-Crine S, Verheij TJ, Little P, Goossens H; on behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf. doi: 10.1136/bmjqs.2010.049049
11. Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, Monnet DL, Little P, Goossens H; ESAC Project Group (2007) European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 16(6):440-445. doi: 10.1136/qshc.2006.021121
12. Pulcini C, Lions C, Ventelou B, Verger P (2012) Drug-specific quality indicators assessing outpatient antibiotic use among French general practitioners. Eur J Public Health. doi: 10.1093/eurpub/cks100
13. Adriaenssens N, Coenen S, Versporten A, Muller A, Vankerckhoven V, Goossens H; ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 66(Suppl 6):vi71-vi77. doi: 10.1093/jac/dkr459
14. Ashworth M, Charlton J, Ballard K, Latinovic R, Gulliford M (2005) Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 55(517):603-608
15. Altiner A, Wilm S, Wegscheider K, Sielk M, Brockmann S, Fuchs A, Abholz HH, In der Schmitten J (2010) Fluoroquinolones to treat uncomplicated acute cough in primary care: predictors for unjustified prescribing of antibiotics. J Antimicrob Chemother 65(7):1521-1525. doi: 10.1093/jac/dkq151
16. Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, Eastaway A, Seaton RA, Watson E, Gillies E, Davey P, Bennie M; Scottish Antimicrobial Prescribing Group (2011) Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 38(1):16-26. doi: 10.1016/j.ijantimicag.2011. 02.005
17. AFSSAPS (Agence française de sécurité sanitaire des produits de santé) (2008) AFSSAPS Practice recommendations for diagnosis and antibiotic therapy of adult community urinary tract infections. Med Mal Infect 38(Suppl 3):S203-S252
18. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72. doi: 10.1086/511159
19. van der Starre WE, van Nieuwkoop C, Paltansing S, van't Wout JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT (2011) Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 66(3):650-656. doi: 10.1093/jac/dkq465
20. Arslan H, Azap OK, Ergönül O, Timurkaynak F; Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56(5):914-918. doi: 10.1093/jac/dki344
21. Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38(7-8):1148-1152. doi: 10.1345/aph.1D622
22. Lin CY, Huang SH, Chen TC, Lu PL, Lin WR, Chen YH (2008) Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. J Microbiol Immunol Infect 41(4):325-331
23. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103-e120. doi: 10.1093/cid/ciq257
24. Klossek JM, Chidiac C, Serrano E, Gehanno P, Naudé P, Amsellem J, Dubreuil C, Ferrand PA, Jankowski R, May T, Bébéar C, Dubreuil L; Groupe d'Etude des Sinusites Infectieuses II (GESI II) (2005) Community-acquired acute maxillary sinusitis or rhinosinusitis in adults in France: current management. Presse Med 34(22 Pt 2):1755-1763
25. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ; European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26(6):1138-1180. doi: 10.1183/09031936.05.00055705
26. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC 3rd, Hudgins PA, Jones S, Krouse HJ, Lee LH, Mahoney MC, Marple BF, Mitchell CJ, Nathan R, Shiffman RN, Smith TL, Witsell DL (2007) Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 137(3 Suppl):S1-S31. doi: 10.1016/j.otohns.2007.06.726
27. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group (2007) European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20:1-136
28. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA; Pneumonia Guidelines Committee of the BTS Standards of Care Committee (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1-iii55. doi: 10.1136/thx.2009.121434
29. Veyssier-Belot C, Lecomte F (2000) Consensus conference on erysipelas and necrotizing fasciitis, Tours, January 26, 2000. Rev Med Interne 21(8):655-658
30. Shahmanesh M, Moi H, Lassau F, Janier M; IUSTI/WHO (2009) 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS 20(7):458-464. doi: 10.1258/ijsa.2009.009143
31. Ross JD; European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization (2001) European guideline for the management of pelvic inflammatory disease and perihepatitis. Int J STD AIDS 12(Suppl 3):84-87
32. Pulcini C, Mondain V, Lieutier F, Mousnier A, Roger PM, Dellamonica P (2007) Fluoroquinolone prescriptions in a teaching hospital: a prospective audit. Scand J Infect Dis 39(11-12):1013-1017. doi: 10.1080/00365540701466223